Lenmed Health Pty Ltd has acquired Mediclinic Kathu Pvt Hospital
Lenmed Health Pty Ltd has acquired the Mediclinic Kathu Pvt Hospital from Mediclinic Southern Africa for US$2 million.
Lenmed Health is an established black-owned hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana and managing in excess of 1,300 beds.
The Mediclinic Kathu private hospital is situated in the iron ore capital of the Northern Cape between Upington and Vryburg.
Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia, focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings. The group currently operates 49 private hospitals in South Africa and 3 in Namibia, with more than 7,000 beds in total. Mediclinic Southern Africa is a wholly owned subsidiary of the South Africa-based international private healthcare group Mediclinic International, founded in 1983 and listed on the JSE since 1986.
Oaklins' team in South Africa advised the buyer in this transaction.


Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more